Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emcure Pharmaceuticals Limited Call Transcript 2025

Jul 28, 2025

60464_rns_2025-07-28_4900a2c3-8db0-4b7f-ab99-bce50c58eb02.pdf

Call Transcript

Open in viewer

Opens in your device viewer

Emcure

Ref: EPL/CS/SE/0060/2025

Date: July 28, 2025

To,

National Stock Exchange of India Limited
Exchange Plaza, C-1, Block G,
Bandra Kurla Complex, Bandra (East),
Mumbai – 400 051
Script Symbol: EMCURE
BSE Limited
P J Towers,
Dalal Street,
Mumbai- 400 001
Scrip Code/Symbol: 544210/ EMCURE

Dear Sir/Madam,

Subject: Intimation for Earnings Call – Q1 FY26

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform that the Earnings Call for Investors/ Analysts will be held on Thursday , August 07, 2025 at 3:30 p.m. (IST) to discuss the Company's unaudited financial results (standalone and consolidated) and performance for the quarter ended June 30, 2025.

The details of the aforesaid earnings call for Investors/Analysts is enclosed.

The transcript and the audio recording of the Earnings Call will be made available on the Company’s website i.e. www.emcure.com and will be intimated accordingly.

You are requested to take the above information on your records.

Thanking you,

For Emcure Pharmaceuticals Limited

Digitally signed CHETAN by CHETAN RAJENDRA RAJENDRA SHARMA SHARMA Date: 2025.07.28 17:37:15 +05'30'

Chetan Sharma Company Secretary & Compliance Officer Membership Number: F8352

Emcure Pharmaceuticals Limited

Registered Office : Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: [email protected] Website: www.emcure.com CIN: L24231PN1981PLC024251

==> picture [202 x 77] intentionally omitted <==

Emcure Pharmaceuticals Ltd. Q1FY26 Results Earnings Call

Date: Thursday, Aug 07, 2025 Time: 3:30 pm – 4:30 pm IST Dial – in Numbers: Universal Access Number: +91 22 6280 1220 +91 22 7115 8122

Hong Kong: 800 964 448 Singapore: 800 101 2045 UK: 080 8101 1573 USA: 186 674 62133

- To pre register online, please click here

For any clarification, please contact: E-mail: [email protected]